Z51.0

Billable

Encounter for antineoplastic radiation therapy

Encounter for antineoplastic radiation therapy

Status

Billable / Specific

Block

Z40-Z53

Parent Code

Z51

Coding Notes

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

  • follow-up examination after treatment (Z08-Z09)

Excludes 2

Conditions not included here, but the patient may have both

  • follow-up examination for medical surveillance after treatment (Z08-Z09)

Code Also

A second code may be required; sequencing depends on circumstances

  • condition requiring care

Also Known As / Clinical Terms

Frequently Asked Questions

What is ICD-10 code Z51.0?

ICD-10-CM code Z51.0 represents "Encounter for antineoplastic radiation therapy". It is a billable/specific code that can be used on a claim.

Is Z51.0 a billable code?

Yes, Z51.0 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is Z51.0 in?

Z51.0 is in Chapter 22: Factors Influencing Health Status and Contact With Health Services (codes Z00-Z99).

What codes cannot be used with Z51.0?

Z51.0 has Excludes1 notes indicating codes that cannot be used together with it, including: follow-up examination after treatment (Z08-Z09).

What SNOMED CT codes does Z51.0 map to?

Z51.0 maps to 2 SNOMED CT concepts: 396780003, 168531007. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for Z51.0?

Z51.0 is linked to 1 UMLS Concept Unique Identifier: C2910942. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.